Evidence map›Paper›PMID 9091579›Full record

ArticleThe Journal of experimental medicine1997

RAFTK, a novel member of the focal adhesion kinase family, is phosphorylated and associates with signaling molecules upon activation of mature T lymphocytes.

R K Ganju, W C Hatch, H Avraham, M A Ona, B Druker, S Avraham, J E Groopman

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 103 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Eph/ephrin signaling in cell-cell and cell-substrate adhesion.Frontiers in bioscience (Landmark edition) · 2012
    Review
  5. Article
  6. Article
  7. Proline-rich tyrosine kinase-2 is critical for CD8 T-cell short-lived effector fate.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

R K GanjuDivision of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
W C Hatch
H Avraham
M A Ona
B Druker
S Avraham
J E Groopman
Harvard University · USBeth Israel Deaconess Medical Center · US

Funding

PATHOBIOLOGY OF HIV SUPPRESSION OF HEMATOPOIESISR01HL053745 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GROOPMAN, JEROME E · 1994 to 2004
$2.1M
THROMBOPOIETIN FOR AIDS RELATED THROMBOCYTOPOIESISR01HL055187 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GROOPMAN, JEROME E · 1995 to 1998
–
NHLBI NIH HHS HL 43510-07NHLBI NIH HHS HL 53745-02NHLBI NIH HHS HL 55187-01NHLBI NIH HHS R01 HL053745
6 · The paper itself

Abstract

The related adhesion focal tyrosine kinase (RAFTK), a recently discovered member of the focal adhesion kinase family, has previously been reported to participate in signal transduction in neuronal cells, megakaryocytes, and B lymphocytes. We have found that RAFTK is constitutively expressed in human T cells and is rapidly phosphorylated upon the activation of the T cell receptor (TCR). This activation also results in an increase in the autophosphorylation and kinase activity of RAFTK. After its stimulation, there was an increase in the association of the src cytoplasmic tyrosine kinase Fyn and the adapter protein Grb2. This association was mediated through the SH2 domains of Fyn and Grb2. RAFTK also co-immunoprecipitates with the SH2 domain of Lck and with the cytoskeletal protein paxillin through its COOH-terminal proline-rich domain. The tyrosine phosphorylation of RAFTK after T cell receptor-mediated stimulation was reduced by the pretreatment of cells with cytochalasin D, suggesting the role of the cytoskeleton in this process. These observations indicate that RAFTK participates in T cell receptor signaling and may act to link signals from the cell surface to the cytoskeleton and thereby affect the host immune response.

Indexed as

Adaptor Proteins, Signal TransducingLymphocyte ActivationSignal TransductionCalciumCells, CulturedCytoskeletal ProteinsCytoskeletonFocal Adhesion Kinase 2GRB2 Adaptor ProteinHumansKineticsPaxillinPhosphoproteinsPhosphorylationPhosphotyrosineProtein BindingAdaptor Proteins, Signal TransducingCalciumCytoskeletal ProteinsFocal Adhesion Kinase 2FYN protein, humanGRB2 Adaptor ProteinGRB2 protein, humanPaxillinPhosphoproteinsPhosphotyrosineProteinsProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-fynPXN protein, humanReceptors, Antigen, T-Cell

Identifiers

PMID9091579
PMCPMC2196239
OpenAlexW2125816390

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.